Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTHR
4351
DELISTED
Charles & Colvard Ltd
CTHR
| $19.5K | ﹤0.01% |
20,334
+3,393
| +20% | +$4.48K |
|
|
BBLG
4352
Bone Biologics
BBLG
$1.53M
| $19.4K | ﹤0.01% |
4,034
+1,475
| +58% | +$8.55K |
|
|
LDTC
4353
DELISTED
LeddarTech
LDTC
| $19.4K | ﹤0.01% |
42,094
| – | – |
|
4354
Motorsport Games
MSGM
$18.1M
| $19.3K | ﹤0.01% |
18,384
+6,140
| +50% | +$7.93K |
|
|
KAPA
4355
Kairos Pharma
KAPA
$6.55M
| $19.1K | ﹤0.01% |
+20,433
| New | +$26.2K |
|
|
CTOR
4356
Citius Oncology
CTOR
$55.1M
| $19.1K | ﹤0.01% |
20,539
+7,888
| +62% | +$8.45K |
|
|
ORBS
4357
Eightco Holdings
ORBS
$234M
| $19.1K | ﹤0.01% |
17,815
+3,987
| +29% | +$6K |
|
4358
Beneficient
BENF
$46.4M
| $18.9K | ﹤0.01% |
7,569
+4,523
| +148% | +$18.2K |
|
|
XAGE
4359
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| $18.8K | ﹤0.01% |
5,001
+1,763
| +54% | +$17.1K |
|
|
XXII
4360
22nd Century Group
XXII
$1.38M
| $18.7K | ﹤0.01% |
+2
| New | +$47.6K |
|
4361
Catheter Precision
VTAK
$906K
| $18.6K | ﹤0.01% |
+2,853
| New | +$21.6K |
|
4362
Strive Inc
ASST
$934M
| $18.6K | ﹤0.01% |
+1,617
| New | +$20K |
|
|
LSH
4363
Lakeside Holding Ltd
LSH
$9.6M
| $18.6K | ﹤0.01% |
17,180
+5,786
| +51% | +$10.3K |
|
4364
Super League Enterprise
SLE
$4.28M
| $18.5K | ﹤0.01% |
164
+58
| +55% | +$13.9K |
|
4365
Expion360
XPON
$3.44M
| $18.5K | ﹤0.01% |
+1,712
| New | +$27.8K |
|
4366
Snail Inc
SNAL
$41.9M
| $18.5K | ﹤0.01% |
4,203
+414
| +11% | +$4.07K |
|
|
SOPA
4367
DELISTED
Society Pass
SOPA
| $18.3K | ﹤0.01% |
20,202
+7,282
| +56% | +$11.3K |
|
|
AHG
4368
Akso Health Group
AHG
$1.35B
| $18.3K | ﹤0.01% |
14,973
| – | – |
|
|
NBP
4369
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $18.2K | ﹤0.01% |
22,037
| – | – |
|
4370
Volato Group
SOAR
$7.24M
| $18.1K | ﹤0.01% |
10,480
+6,274
| +149% | +$23.2K |
|
|
SYRA
4371
DELISTED
Syra Health Corp. Class A Common Stock
SYRA
| $17.9K | ﹤0.01% |
68,816
+45,332
| +193% | +$19K |
|
4372
Oragenics
OGEN
$2.26M
| $17.8K | ﹤0.01% |
2,828
+1,545
| +120% | +$13.4K |
|
|
NAKA
4373
Nakamoto Inc
NAKA
$82.7M
| $17.7K | ﹤0.01% |
+275
| New | +$18.6K |
|
|
FOXO
4374
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| $17.7K | ﹤0.01% |
7,238
+5,104
| +239% | +$20.9K |
|
|
MSPR
4375
DELISTED
MSP Recovery Inc
MSPR
| $17.6K | ﹤0.01% |
+1,983
| New | +$28.6K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.